HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacological preconditioning with the adenosine triphosphate-sensitive potassium channel opener pinacidil.

AbstractBACKGROUND:
Ischemic preconditioning (IPC) decreases infarct size after global or regional ischemia. Potassium channel openers also precondition but are subject to dose-limiting vasodilation. We compared the mechanical and electrophysiological effects of ischemic and pharmacological preconditioning in an isolated rabbit heart model.
METHODS:
Rabbit hearts were preconditioned with either 10 micromol/L pinacidil alone (P-), 10 micromol/L pinacidil with 10 micromol/L phenylephrine (P+), or two cycles of global ischemia and reperfusion (IPC) before 1 hour of LAD occlusion. Left ventricular pressure, epicardial monophasic action potential duration (APD) and coronary flow were monitored throughout. Infarct size was determined at the end of reperfusion.
RESULTS:
Regional ischemia uniformly decreased APD (p<0.05). During reperfusion, APDs were prolonged beyond preischemic values in all preconditioned groups (p<0.05). P- and P+ reduced the incidence of fibrillation. P- significantly increased coronary flow (+15%, p = 0.001), whereas IPC and P+ did not. However, IPC and P- significantly decreased systolic function (p<0.05) but P+ did not. In addition, IPC depressed diastolic function (p<0.05) but P- and P+ did not. Infarct size was reduced by all methods (p<0.05).
CONCLUSIONS:
Pinacidil presents a safe and effective alternative to IPC for preserving the heart during regional ischemia. Its coronary vasodilatory effects are safely and effectively reversed by the addition of phenylephrine.
AuthorsA E Saltman, I B Krukenkamp, G R Gaudette, H Horimoto, S Levitsky
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 70 Issue 2 Pg. 595-601 (Aug 2000) ISSN: 0003-4975 [Print] Netherlands
PMID10969686 (Publication Type: Journal Article)
Chemical References
  • Vasodilator Agents
  • Pinacidil
Topics
  • Action Potentials (drug effects)
  • Animals
  • Coronary Circulation
  • Heart (drug effects)
  • Ischemic Preconditioning, Myocardial (methods)
  • Male
  • Pinacidil (pharmacology)
  • Rabbits
  • Vasodilator Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: